NAVCO Pharmaceuticals Inc (TSE:NAV) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NAVCO Pharmaceuticals Inc. successfully concluded its Annual General Meeting, with all proposed resolutions passed, including the election of four directors and the appointment of a new auditor. Shareholders approved a new share option plan that aligns with updated TSX Venture Exchange policies and allows for cashless option exercises. The company, which specializes in nanotechnology-based products for combating various pathogens, continues to strengthen its market position in health and personal care sectors.
For further insights into TSE:NAV stock, check out TipRanks’ Stock Analysis page.